The Wilms tumor 1 (WT1) gene, a zinc finger transcription factor implicated in leukemogenesis, is overexpressed in 70% of AML patients [78,79] and has been targeted through the adoptive transfer of WT1-specific CD8(+) cytotoxic T-cell clones. Here, WT1 is linked to acute myeloid leukemia.